ACH-3102

Achillion Says Hepatitis C Drug Subdues Virus in 63% of Patients

Achillion Says Hepatitis C Drug Subdues Virus in 63% of Patients

Bloomberg

5 Drug Hopefuls That Are Going to Change Your Life: Part 2

5 Drug Hopefuls That Are Going to Change Your Life: Part 2

Motley Fool

Achillion Announces Positive Proof-of-Concept Data With ACH-3102

Achillion Announces Positive Proof-of-Concept Data With ACH-3102

Yahoo

Achillion's hepatitis C drug gets FDA fast track

Achillion's hepatitis C drug gets FDA fast track

Reuters

5 Biotech Stocks That Could Soar On New Hepatitis C Drugs

5 Biotech Stocks That Could Soar On New Hepatitis C Drugs

Seeking Alpha

Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C

Achillion Announces 94 - 100% Complete EVR From Phase 2 Trial With ACH-1625 Based Regimen in Hepatitis C

Yahoo/Globe NewsWire